SkyDrive and Suzuki to Collaborate on Business and Technology of Flying Cars

– Start Consideration of Development and Production of Flying Cars, and Market Development in India

TOYOTA, Japan and HAMAMATSU, Japan, March 25, 2022 /PRNewswire/ — SkyDrive Inc. (hereinafter “SkyDrive”) and Suzuki Motor Corporation (hereinafter “Suzuki”) jointly announced on March 22 a partnership for the commercialization of flying cars (*).

SkyDrive is a leading manufacturer of flying cars in Japan and is currently engaged in the development of a compact, two-seater electric-powered flying car with plans for full-scale production.

Suzuki is one of Japan’s leading automakers with expertise that includes manufacturing and selling compact cars in international markets.

Under the terms of the agreement, SkyDrive and Suzuki will start consideration to collaborate in areas of business and technology that include technology R&D, planning of manufacturing and mass-production systems, development of overseas markets with an initial focus on India, and promotion of efforts to attain carbon neutrality.

SkyDrive aims to begin air taxi service during the 2025 World Exposition in Osaka, Japan, as well as to initiate service in other regions of Japan.

Suzuki, which has the company motto “Develop products of superior value by focusing on the customer,” currently offers products in three mobility categories — automobiles, motorcycles, and outboard motors. The company aims to remain indispensable to people by staying closely attuned to their lives and providing mobility. The partnership with SkyDrive will provide Suzuki with opportunities to explore and potentially add flying cars as a fourth mobility business.

About SkyDrive Inc.

SkyDrive was established in July 2018 with the mission of “leading a once-in-a-century mobility revolution.” Since then, it has advanced the development of flying cars and cargo drones while working in partnership with others to promote the shared vision of a future in which people use air mobility as a means of transportation in their daily lives. SkyDrive is the only company in Japan that has successfully conducted manned test flights and is now involved in designing a system for future air mobility as a member of Japan’s public-private council for advanced air mobility. The company’s cargo drones, which can carry payloads of up to 30kg, are already being used at worksites in Japan, mainly in mountainous areas. SkyDrive is aiming to launch a flying car service in the Osaka Bay area in 2025. SkyDrive has  headquarters in Shinjuku, Tokyo. Tomohiro Fukuzawa is CEO of the company.

For more information, please visit: https://en.skydrive2020.com/

About Suzuki Motor Corporation

Suzuki Motor Corporation is one of Japan’s leading carmakers and a global motorcycle manufacturer. The company’s non-vehicle products include outboard motors for boats and motorized wheelchairs. It builds its lineup on its own and through numerous subsidiaries and joint ventures outside Japan. Suzuki was established in 1920 and has headquarters in Hamamatsu, Shizuoka. Toshihiro Suzuki is President of the company.

Website: https://www.globalsuzuki.com/

Editor’s Note:

(*) Flying cars are formally known as eVTOL (electric vertical takeoff and landing) aircraft. eVTOL is characterized by electrification, a fully autonomous autopilot, and vertical takeoff and landing. As a new advancement in the field of mobility, the development of flying cars is being promoted in many countries around the world. In Japan, the Public-Private Council for Air Mobility Revolution was established in 2018 with meetings held since then. The project is expected to lead to taxi services in urban areas, new means of transportation for remote islands and mountainous areas, and emergency transportation in times of disaster. A roadmap has been formulated by the Ministry of Economy, Trade, and Industry (METI) and the Ministry of Land, Infrastructure, Transport, and Tourism (MLIT) for the start of business in 2023 and full-scale deployment in 2030.

AKBA INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AKBA

NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28, 2018 and September 2, 2020, inclusive (the “Class Period”), of the important May 13, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Akebia securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Akebia class action, go to https://rosenlegal.com/submit-form/?case_id=4028 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 13, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) vadadustat was not as safe in treating NDD-CKD patients with anemia as defendants had represented; (2) as a result, defendants overstated the PRO2TECT Program’s clinical prospects; (3) accordingly, defendants also overstated vadadustat’s overall commercial and regulatory prospects; and (4) as a result, Akebia’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Akebia class action, go to https://rosenlegal.com/submit-form/?case_id=4028 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Breaches of Fiduciary Duties and Negligence by The Vanguard Group, Inc., Vanguard Chester Funds, and Certain Officers and Trustees – VTWNX, VTTVX, VTHRX, VTTHX, VFORX, VTIVX, VFIFX

NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties and negligence by The Vanguard Group, Inc., Vanguard Chester Funds, and certain officers and trustees (MUTF: VTWNX, VTTVX, VTHRX, VTTHX, VFORX, VTIVX, VFIFX) resulting from allegations that management may have issued materially misleading information to the investing public.

If you invested in Vanguard’s retail funds, held these funds in taxable accounts, and received 2021 capital gains distributions, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=4732 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

ROSEN, NATIONAL TRIAL LAWYERS, Encourages TaskUs, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – TASK

NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TaskUs, Inc. (NASDAQ: TASK) between June 11, 2021 and January 19, 2022, inclusive (the “Class Period”), of the important April 25, 2022 lead plaintiff deadline.

SO WHAT: If you purchased TaskUs securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the TaskUs class action, go to https://rosenlegal.com/submit-form/?case_id=3647 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 25, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) TaskUs was experiencing severe financial strain and business challenges, particularly with its most important customer Facebook; (2) the Content Security market was smaller than defendants represented and defendants’ representations were based on outdated market data; (3) TaskUs improperly recognized revenue from certain key contracts; (4) defendants overstated the size of TaskUs’ workforce as well as employee retention rates, and understated attrition rates; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TaskUs class action, go to https://rosenlegal.com/submit-form/?case_id=3647 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

‫تنشئ Dante Labs أول مجالس Medical Genomics Boards إقليمية لعلم الجينوم الطبي في أوروبا مكونة من قادة عالميين محليين ومتعددي الجنسيات في علم الجينوم

نيويورك، 24 مارس 2022 (GLOBE NEWSWIRE) – Dante Labsأعلنت الشركة الرائدة عالمياً في علم الجينوم والطب الدقيق عن إنشاء أول مجالس للجينوميات الطبية Medical Genomics Boards، مما يعزز مهمة الشركة ونشاطها البحثي في هذه المجالات الجديدة للرعاية الصحية، باستخدام علم الجينوم لتعزيز الوقاية والعلاج.

يتكون مجلس علم الجينوم الطبي Medical Genomics Board من قادة العالم في علم الجينوم من ذوي الخبرات متعددة التخصصات مع العلماء والمتخصصين في علم الجينوم المؤهلين، بما في ذلك علماء الوراثة والكيمياء الحيوية الجزيئية والخبراء السريريين في علم الجينوميات الصيدلانية وعلم الجينوميات الغذائية وعلم الجينوميات والأمراض النادرة قبل الولادة والرُّضَّع حديثي الولادة والأطفال.

وفي معرض تعليقه على هذه المناسبة، قال Andrea Riposati، الرئيس التنفيذي لـ Dante Labs: “إن الهدف هو متابعة مسار الخرائط العلاجية الشخصية من خلال تنظيم نظام إبلاغ واضح على الرغم من التعقيد الكبير للبيانات المستمدة من تسلسل الجينوم الكامل في NGS”. وأضاف “تعتزم Dante إنشاء المزيد من مجالس الجينوميات الطبية الإقليمية Medical Genomics Boards حول العالم لجعل علم الجينوميات في طليعة الطب الدقيق في الرعاية الصحية، مع مراعاة الاعتبارات الإقليمية والثقافية لكل منطقة.”

عُقدت المائدة المستديرة الأولى للجنة المشكلة حديثًا في 10 مارس 2022 في كاستل غاندولفو. تم تشكيل Board رسميًا في ذلك الوقت. وتم تكليف الأستاذ/ Giuseppe Novelli، باحث في الأمراض الوراثية متعددة العوامل، بدور المدير العلمي، وسينسق أنشطة المجلس، وسيكون مستشارًا تقنيًا علميًا.

يأتي أعضاء Board جميعًا من خلفيات طبية وأكاديمية، بما في ذلك الأطباء والصيادلة وعلماء الأحياء. تم اختيار هؤلاء الخبراء في علوم “Omic” لتغطية جميع المجالات العلاجية، من علم الجينوم الوراثي إلى علم الصيدلة الجينومي. وعلى وجه التحديد، من بينهم أستاذ الأمراض الجلدية في جامعة سابينزا في روما، Giovanni Pellacani؛ البروفيسورة Laura di Renzo، من عيادة Tor Vergata الشاملة في روما حيث تتعامل مع علم الوراثة التغذوية وعلم المورثات الغذائية؛ أستاذ الكيمياء الحيوية السريرية والبيولوجيا الجزيئية بجامعة تور فيرغاتا، Sergio Bernardini؛ البروفيسور Antonio Novelli، الذي يتعامل مع علم الجينوم في التشخيص قبل الولادة في مستشفى Bambino Gesù Children’s Hospital في روما؛ وأستاذ الطب الباطني في جامعة سابينزا في روما، Salvatore Minisola. الدكتورة Camilla Nero، خبيرة في علم الأورام من الجامعة الكاثوليكية في روما.

نبذة عن Dante Labs

إنَّ Dante Labs هي شركة بيانات جينومية عالمية تختص ببناء وتسويق فئة جديدة من تطبيقات الصحة التحويلية وطول العمر بناءً على السلسلة الجينومية الكاملة والذكاء الاصطناعي. تتضمن أصولنا واحدة من أكبر قواعد البيانات الجينومية الخاصة التي تم جمعها بموجب موافقات على إجراء الدراسات البحثية، ومنصة برمجيات مسجلة الملكية مصممة لإطلاق العنان لقوة البيانات الجينومية على نطاق واسع، وعمليات مسجلة الملكية تتيح لنا اتباع نهج صناعي لتحديد التسلسل الجيني.

جهة الاتصال:

Laura D’Angelo
نائب رئيس علاقات المستثمرين
0671 191 0862 39+
ir@dantelabs.com
www.dantelabs.com

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TAL Education Group Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – TAL

NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TAL Education Group (NYSE: TAL) between April 26, 2018 and July 22, 2021, inclusive (the “Class Period”), of the important April 5, 2022 lead plaintiff deadline.

SO WHAT: If you purchased TAL Education securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the TAL Education class action, go to https://rosenlegal.com/submit-form/?case_id=3137 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 5, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) TAL Education’s revenue and operational growth was the result of deceptive marketing tactics and illicit business practices that flouted Chinese laws, regulations, and policies, and exposed TAL Education to an extreme risk that more draconian measures would be imposed on TAL Education; (2) TAL Education had engaged in misleading and fraudulent advertising practices, including the provision of false and misleading discount information designed to obfuscate the true cost of TAL Education’s programs to its customers, the creation of fake customer reviews designed to fraudulently lure new customers to TAL Education programs, the misrepresentation of teacher qualifications and course qualities, and the marketing of rigged promotional events; (3) TAL Education had defied Chinese policies designed to alleviate the burden imposed by tutoring services on students and their families, including by imposing hefty advances and recurring debt payments on course enrollees, by offering courses designed to give affluent students unfair advantages, by holding courses outside of allowable tutoring hours, and by linking for-profit courses to government-mandated schooling; (4) as a result, TAL Education was subject to an extreme undisclosed risk of adverse enforcement actions, regulatory fines, and penalties, and the imposition of new rules and regulations adverse to TAL Education’s business and financial interests; and (5) consequently, TAL Education’s historical growth was not sustainable or the result of legitimate business tactics as represented, and defendants’ positive statements about TAL Education’s business, operations, and prospects were materially false and misleading and lacked a reasonable factual basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TAL Education class action, go to https://rosenlegal.com/submit-form/?case_id=3137 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com